Pyoderma gangrenosum arising during treatment of psoriasis with adalimumab: Effectiveness of ustekinumab-Reference-Cited by-同舟云学术

Pyoderma gangrenosum arising during treatment of psoriasis with adalimumab: Effectiveness of ustekinumab

Published:2017-06-28 Issue:4 Volume:58 Page:e270-e271
ISSN:0004-8380
Container-title:Australasian Journal of Dermatology
language:en
Short-container-title:Australas J Dermatol

Author:

Benzaquen Michael¹,Monnier Jilliana¹,Beaussault Yasmine¹,Rouby Frank²,Berbis Philippe¹

Affiliation:

1. Service de Dermatologie; Hôpital Nord and; Marseille France

2. Centre Régional de Pharmacovigilance Marseille Provence Corse; Service de Pharmacologie Clinique; Hôpital Timone; Marseille France

Publisher

Wiley

Subject

Dermatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ajd.12545/fullpdf

Reference5 articles.

1. Paradoxical reaction to etanercept: development of pyoderma gangraenosum during therapy of psoriasis arthritis;Kowalzick;J. Dtsch. Dermatol. Ges.,2013

2. Late paradoxical development of pyoderma gangrenosum in a psoriasis patient treated with infliximab;Vestita;Eur. J. Dermatol.,2015

3. Effective strategies for the management of pyoderma gangrenosum: a comprehensive review;Patel;Acta Derm. Venereol.,2015

4. Anti-TNF antibody-induced psoriasiform skin lesions in patients with inflammatory bowel disease are characterised by interferon-γ-expressing Th1 cells and IL-17A/IL-22-expressing Th17 cells and respond to anti-IL-12/IL-23 antibody treatment;Tillack;Gut,2014

5. Interleukin 23 expression in pyoderma gangrenosum and targeted therapy with ustekinumab;Guenova;Arch. Dermatol.,2011

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ustekinumab: In Psoriasis and Beyond —A Derm atological Perspective;Journal of Pharmacology and Pharmacotherapeutics;2024-05-08

2. The Pathophysiology and Treatment of Pyoderma Gangrenosum—Current Options and New Perspectives;International Journal of Molecular Sciences;2024-02-19

3. Paradoxical Reaction to TNF-α Inhibitor Therapy in a Patient With Hidradenitis Suppurativa;Cutis;2023-11

4. Journal Club: Update on pyoderma gangrenosum;European Journal of Dermatology;2023-10

5. Pyoderma gangraenosum als diagnostische und therapeutische interdisziplinäre Herausforderung;Aktuelle Dermatologie;2023-07